QA: Acer Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069308_2023_Acer_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001069308, Acer Therapeutics Inc.

  xvar xval
0 AssetsCurrent 3,516,698
1 IntangibleAssetsNetIncludingGoodwill 7,647,267
2 PropertyPlantAndEquipmentNet 214,578
3 remainder_Assets 245,683
4 LiabilitiesCurrent 18,951,700
5 LiabilitiesNoncurrent 145,665
6 remainder_Liabilities 9,288,133
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,689,422
9 ResearchAndDevelopmentExpense 11,924,837
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,623,056
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 11,624,226
1 Liabilities 28,385,498
2 Expenses 24,614,259
3 Revenues 0
4 StockholdersEquity -16,761,272
5 NetIncome -26,237,315
6 ComprehensiveNetIncome -26,237,315
7 BaseVar 33,123,520
8 EconomicCapitalRatio -2.75

Edgar->Model Mapping

Feature Distribution

Change over Time